These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31622668)

  • 1. Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis.
    He H; Li R; Choi S; Zhou L; Pavel A; Estrada YD; Krueger JG; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):70-78. PubMed ID: 31622668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
    Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
    Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.
    Brunner PM; He H; Pavel AB; Czarnowicki T; Lefferdink R; Erickson T; Canter T; Puar N; Rangel SM; Malik K; Estrada Y; Krueger JG; Guttman-Yassky E; Paller AS
    J Am Acad Dermatol; 2019 Aug; 81(2):510-519. PubMed ID: 31009665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
    He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
    J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
    Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.
    Pavel AB; Zhou L; Diaz A; Ungar B; Dan J; He H; Estrada YD; Xu H; Fernandes M; Renert-Yuval Y; Krueger JG; Guttman-Yassky E
    J Am Acad Dermatol; 2020 Mar; 82(3):690-699. PubMed ID: 31669080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
    Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB;
    Front Immunol; 2018; 9():630. PubMed ID: 29966024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.
    Zhou L; Leonard A; Pavel AB; Malik K; Raja A; Glickman J; Estrada YD; Peng X; Del Duca E; Sanz-Cabanillas J; Ruano J; Xu H; Zhang N; Wen HC; Gonzalez J; Garcet S; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Jul; 144(1):144-156. PubMed ID: 30685456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
    Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
    J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic characterization of atopic dermatitis blood from infancy to adulthood.
    Del Duca E; Renert-Yuval Y; Pavel AB; Mikhaylov D; Wu J; Lefferdink R; Fang M; Sheth A; Blumstein A; Facheris P; Estrada YD; Rangel SM; Krueger JG; Paller AS; Guttman-Yassky E
    J Am Acad Dermatol; 2023 May; 88(5):1083-1093. PubMed ID: 36773824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
    He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
    Front Immunol; 2020; 11():1768. PubMed ID: 32849633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y; Takehara K; Sato S
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
    Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
    J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset pediatric atopic dermatitis is T
    Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
    Ahrens B; Schulz G; Bellach J; Niggemann B; Beyer K
    Pediatr Allergy Immunol; 2015 Nov; 26(7):634-40. PubMed ID: 26102348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood.
    Czarnowicki T; David E; Yamamura K; Han J; He H; Pavel AB; Glickman J; Erickson T; Estrada Y; Krueger JG; Rangel SM; Paller AS; Guttman-Yassky E
    Allergy; 2024 Oct; 79(10):2732-2747. PubMed ID: 39003573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis.
    Hayashida S; Uchi H; Moroi Y; Furue M
    J Dermatol Sci; 2011 Mar; 61(3):180-6. PubMed ID: 21255981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers.
    Hon KL; Tsang KY; Kung JS; Leung TF; Lam CW; Wong CK
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28216598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.